(Q47858891)
Statements
A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia (English)
J F Doherty
M Pinder
N Tornieporth
C Carton
L Vigneron
C A Holland
K E Kester
G Voss
P Momin
B M Greenwood
K P McAdam